Chemo Helps Elderly Lung Cancer Patients, Too
WKYT 27 NEWSFIRST & WYMT Mountain News - Jun 04 12:51 AM
FRIDAY, June 2 (HealthDay News) — Don’t ignore the elderly when it comes to giving chemotherapy after lung cancer surgery, new research suggests.Save to My Web
Cabrellis Pharmaceuticals Initiates Phase II Study of Calsed(TM) in Small Cell Lung Cancer
[Press Release] Business Wire via Yahoo! Finance - Jun 05 5:35 AM
SAN DIEGO—-June 5, 2006–Cabrellis Pharmaceuticals Corporation today announced the initiation of a phase II clinical trial of its totally synthetic, next-generation anthracycline, Calsed , in small cell lung cancer .Save to My Web
DAILY CHECK-UP
Lexington Herald-Leader - Jun 08 12:06 AM
There is evidence that asbestos can cause cancer of the larynx, the Institute of Medicine reported Tuesday. Asbestos has long been associated with lung cancer and mesothelioma, a rare cancer of the lining of the chest and abdomen. The Senate asked the institute, an arm of the National Academy of Sciences, to look into the possibility that other forms of cancer could also be related to the fibrous Save to My Web
Lucanix Phase II Clinical Data Demonstrates Significantly Increased Survival in Lung Cancer Patients
[Press Release] PR Newswire via Yahoo! Finance - Jun 05 5:00 AM
NovaRx Corporation announced at the American Society of Clinical Oncology meeting in Atlanta, GA, that data from the Company’s Phase II clinical trial treating individuals with advanced stages of non-small cell lung cancer demonstrated two year-survival more than four times that of individuals treated with the current standard of care.Save to My Web
Shipwreck survivor recounts saga of 1942 ‘lifeboat baby’
Richmond Times-Dispatch - Jun 10 10:19 PM
VIRGINIA BEACH Last year I reconstructed the story of a woman who gave birth in a lifeboat in a storm off Cape Hatteras, N.C., after her ship was torpedoed by a German U-boat in 1942.Save to My Web
Results of Key Phase II Studies Demonstrate Progression Free Survival Advantage for ZD6474 (ZACTIMA) in Lung Cancer
Presseportal - Jun 04 11:09 PM
Atlanta (ots/PRNewswire) - - Enrolment to a Pivotal Phase III Study of ZD6474 in Advanced Non-Small Cell Lung Cancer (NSCLC) is Also Underway AstraZeneca today announced at the annual meeting of the American Society of Clinical Oncology …Save to My Web
Three Studies Confirm Activity of ABRAXANE As First-Line Treatment in Non-Small Cell Lung Cancer and Show Higher Tumor
[Press Release] Business Wire via Yahoo! Finance - Jun 04 5:00 AM
ATLANTA—-June 4, 2006–Abraxis BioScience, Inc. : Fifty Percent Response Rate and 86 Percent Disease Control Observed With Weekly ABRAXANE in Combination with Carboplatin Positive Data Forms the Basis for Phase Three Registration Trial in Lung CancerSave to My Web
New Predictor for Lung Cancer Found
RedNova - Jun 08 11:15 AM
U.S. researchers say they have found a promising, novel biomarker that may predict the survival of people with advanced lung cancer.Save to My Web